Prof Michael Friedlander

Prof Michael Friedlander is a well-respected medical oncologist specialising in the treatment of breast and gynaecological cancers. Currently holding the position of conjoint Professor of Medicine at the University of New South Wales, he is based in Randwick, Sydney, Australia.

Prof Friedlander practices primarily at the renowned Prince of Wales Private Hospital and the Royal Hospital for Women, where he has successfully treated numerous patients. With extensive experience and expertise in his field, he has dedicated his career to advancing the understanding and management of cancers affecting women.

Prof Friedlander boasts an impressive academic background. He is a member of the Royal College of Physicians of London since 1978 and received his Fellowship of the Royal Australasian College of Physicians in 1984. Graduating with a Bachelor of Medicine and Bachelor of Surgery (MBChB) from the University of Birmingham in 1975, he possesses a strong foundation in medical education.

As a testament to his commitment to professional growth and ongoing learning, Prof Friedlander actively engages in clinical research and holds a PhD. His research interests are diverse, with a primary focus on gynaecological cancers, breast cancer, soft tissue sarcomas, and germ cell tumours. Prof Friedlander has played a pivotal role in numerous clinical trials, ensuring that effective treatment plans are developed for women with cancer.

One of Prof Friedlander's notable contributions to the medical field is his expertise in incorporating patient reported outcomes as endpoints into clinical trials. This has proven essential in tailoring treatment plans and improving quality of life for his patients. He has made substantial contributions to gynaecological cancer clinical trials on both national and international levels.

Throughout his career, Prof Friedlander has held several prestigious leadership positions. He was the inaugural chair of the Australia New Zealand Gynecological Oncology Group (ANZGOG) and has served as the Past President of the International Gynaecological Cancer Society (IGCS). These appointments reflect his outstanding reputation and pioneering work in the field.

Prof Friedlander's contributions to the research and treatment of women with breast and gynaecological cancers have been widely acknowledged and celebrated. He has received numerous awards and accolades for his remarkable achievements, making him a highly regarded figure in the medical community.

With his vast knowledge, exceptional skills, and dedication to advancing cancer research and treatment, Prof Michael Friedlander has become an invaluable asset in the medical community. He continues to make significant contributions to the field, providing hope and exceptional care to patients affected by breast and gynaecological cancers.